NMS-P715 is primarily utilized in the field of cancer research, particularly in the study and development of targeted therapies. It functions as a selective inhibitor of specific kinases, which are enzymes that play a critical role in signaling pathways associated with tumor growth and survival. By inhibiting these kinases, NMS-P715 helps researchers understand the mechanisms of cancer progression and evaluate its potential as a therapeutic agent. Its application extends to preclinical studies, where it is used to assess efficacy, safety, and pharmacokinetics in models of various cancers. This compound is particularly valuable in identifying and validating new drug targets for oncology.